Acute exposure to 3‑deoxyglucosone at high glucose levels impairs insulin secretion from β‑cells by downregulating the sweet taste receptor signaling pathway

Song,Xiudao; Liang,Guoqiang; Shi,Min; Zhou,Liang; Wang,Fei; Zhang,Lurong; Huang,Fei; Jiang,Guorong

doi:10.3892/mmr.2019.10163

Acute exposure to 3‑deoxyglucosone at high glucose levels impairs insulin secretion from β‑cells by downregulating the sweet taste receptor signaling pathway

Authors:
- Xiudao Song
- Guoqiang Liang
- Min Shi
- Liang Zhou
- Fei Wang
- Lurong Zhang
- Fei Huang
- Guorong Jiang
View Affiliations

Affiliations: Basic Research Laboratory, Suzhou Academy of Wumen Chinese Medicine, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, Jiangsu 215009, P.R. China
Published online on: April 15, 2019 https://doi.org/10.3892/mmr.2019.10163
Pages: 5015-5022

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Sweet taste receptors (STRs) expressed on β‑cells stimulate insulin secretion in response to an increase in the circulating level of glucose, maintaining glucose homeostasis. 3‑Deoxyglucosone (3DG), a highly reactive α‑dicarbonyl compound, has been previously described as an independent factor associate with the development of prediabetes. In our previous study, pathological plasma levels of 3DG were induced in normal rats with a single intravenous injection of 50 mg/kg 3DG, and an acute rise in circulating 3DG induced glucose intolerance by impairing the function of pancreatic β‑cells. The present study aimed to investigate whether the deleterious effects of pathological plasma levels of 3DG on β‑cell function and insulin secretion were associated with STRs. INS‑1 cells, an in vitro model to study rat β‑cells, were treated with various concentrations of 3DG (1.85, 30.84 and 61.68 mM) or lactisole (5 mM). Pancreatic islets were collected from rats 2 h after a single intravenous injection of 50 mg/kg 3DG + 0.5 g/kg glucose. The insulin concentration was measured by ELISA. The protein expression levels of components of the STR signaling pathways were determined by western blot analysis. Treatment with 3DG and 25.5 mM glucose for 1 h significantly reduced insulin secretion by INS‑1 cells, which was consistent with the phenotype observed in INS‑1 cells treated with the STR inhibitor lactisole. Accordingly, islets isolated from rats treated with 3DG exhibited a significant reduction in insulin secretion following treatment with 25.5 mM glucose. Furthermore, acute exposure of INS‑1 cells to 3DG following treatment with 25.5 mM glucose for 1 h significantly reduced the protein expression level of the STR subunit taste 1 receptor member 3 and its downstream factors, transient receptor potential cation channel subfamily M member 5 and glucose transporter 2. Notably, islet tissues collected from rats treated with 3DG exhibited a similar downregulation of these factors. The present results suggested that acute exposure to pathologically relevant levels of 3DG in presence of high physiological levels of glucose decreased insulin secretion from β‑cells by, at least in part, downregulating the STR signaling pathway.

View Figures

View References

1	Schuit FC, Huypens P, Heimberg H and Pipeleers DG: Glucose sensing in pancreatic beta-cells: A model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus. Diabetes. 50:1–11. 2001. View Article : Google Scholar : PubMed/NCBI
2	Kojima I, Medina J and Nakagawa Y: Role of the glucose-sensing receptor in insulin secretion. Diabetes Obes Metab. 1 (Suppl 19):S54–S62. 2017. View Article : Google Scholar
3	Nelson G, Hoon MA, Chandrashekar J, Zhang Y, Ryba NJ and Zuker CS: Mammalian sweet taste receptors. Cell. 106:381–390. 2001. View Article : Google Scholar : PubMed/NCBI
4	Margolskee RF: Molecular mechanisms of bitter and sweet taste transduction. J Biol Chem. 277:1–4. 2002. View Article : Google Scholar : PubMed/NCBI
5	Depoortere I: Taste receptors of the gut: Emerging roles in health and disease. Gut. 63:179–190. 2014. View Article : Google Scholar : PubMed/NCBI
6	Kyriazis GA, Soundarapandian MM and Tyrberg B: Sweet taste receptor signaling in beta cells mediates fructose-induced potentiation of glucose-stimulated insulin secretion. Proc Natl Acad Sci USA. 109:E524–E532. 2012. View Article : Google Scholar : PubMed/NCBI
7	Nakagawa Y, Nagasawa M, Yamada S, Hara A, Mogami H, Nikolaev VO, Lohse MJ, Shigemura N, Ninomiya Y and Kojima I: Sweet taste receptor expressed in pancreatic beta-cells activates the calcium and cyclic AMP signaling systems and stimulates insulin secretion. PLoS One. 4:e51062009. View Article : Google Scholar : PubMed/NCBI
8	Nakagawa Y, Nagasawa M, Mogami H, Lohse M, Ninomiya Y and Kojima I: Multimodal function of the sweet taste receptor expressed in pancreatic β-cells: Generation of diverse patterns of intracellular signals by sweet agonists. Endocr J. 60:1191–1206. 2013. View Article : Google Scholar : PubMed/NCBI
9	Nakagawa Y, Ohtsu Y, Nagasawa M, Shibata H and Kojima I: Glucose promotes its own metabolism by acting on the cell-surface glucose-sensing receptor T1R3. Endocr J. 61:119–131. 2014. View Article : Google Scholar : PubMed/NCBI
10	Niwa T: 3-Deoxyglucosone: Metabolism, analysis, biological activity, and clinical implication. J Chromatogr B Biomed Sci Appl. 731:23–36. 1999. View Article : Google Scholar : PubMed/NCBI
11	Degen J, Beyer H, Heymann B, Hellwig M and Henle T: Dietary influence on urinary excretion of 3-deoxyglucosone and its metabolite 3-deoxyfructose. J Agric Food Chem. 62:2449–2456. 2014. View Article : Google Scholar : PubMed/NCBI
12	Brings S, Fleming T, Freichel M, Muckenthaler MU, Herzig S and Nawroth PP: Dicarbonyls and advanced glycation end-products in the development of diabetic complications and targets for intervention. Int J Mol Sci. 18:E9842017. View Article : Google Scholar : PubMed/NCBI
13	Lal S, Kappler F, Walker M, Orchard TJ, Beisswenger PJ, Szwergold BS and Brown TR: Quantitation of 3-deoxyglucosone levels in human plasma. Arch Biochem Biophys. 342:254–260. 1997. View Article : Google Scholar : PubMed/NCBI
14	Hamada Y, Nakamura J, Fujisawa H, Yago H, Nakashima E, Koh N and Hotta N: Effects of glycemic control on plasma 3-deoxyglucosone levels in NIDDM patients. Diabetes Care. 20:1466–1469. 1997. View Article : Google Scholar : PubMed/NCBI
15	Jiang G, Zhang L, Ji Q, Wang F, Xu H, Huang F and Wang C: Accumulation of plasma 3-deoxyglucosone impaired glucose regulation in Chinese seniors: Implication for senile diabetes? Diabetes Metab Syndr. 6:140–145. 2012. View Article : Google Scholar : PubMed/NCBI
16	Zhang L, Song X, Zhou L, Liang G, Xu H, Wang F, Huang F and Jiang G: Accumulation of intestinal tissue 3-deoxyglucosone attenuated GLP-1 secretion and its insulinotropic effect in rats. Diabetol Metab Syndr. 8:782016. View Article : Google Scholar : PubMed/NCBI
17	Wang F, Zhou L, Song X, Liang G, Xu H, Zhang L and Jiang G: Acute reduction of incretin effect and glucose intolerance in rats by single intragastric administration of 3-deoxyglucosone. Exp Clin Endocrinol Diabetes. 125:4–11. 2017.PubMed/NCBI
18	Zhang L, Zhou L, Song X, Liang G, Xu Z, Wang F, Huang F and Jiang G: Involvement of exogenous 3-deoxyglucosone in β-cell dysfunction induces impaired glucose regulation. Mol Med Rep. 16:2976–2984. 2017. View Article : Google Scholar : PubMed/NCBI
19	Liang G, Song X, Xu H, Wang F, Zhang L, Zhou L and Jiang G: 3-Deoxyglucosone induced acute glucose intolerance in sprague-dawley rats: Involvement of insulin resistance and impaired β-cell function. Exp Clin Endocrinol Diabetes. 124:431–436. 2016. View Article : Google Scholar : PubMed/NCBI
20	Maessen DE, Hanssen NM, Scheijen JL, van der Kallen CJ, van Greevenbroek MM, Stehouwer CD and Schalkwijk CG: Post-glucose load plasma α-dicarbonyl concentrations are increased in individuals with impaired glucose metabolism and type 2 diabetes: The CODAM study. Diabetes Care. 38:913–920. 2015. View Article : Google Scholar : PubMed/NCBI
21	Feng R, Qian C, Liu Q, Jin Y, Liu L, Li S, Liao Y, Zhou H, Liu W, Rayner CK and Ma J: Expression of sweet taste receptor and gut hormone secretion in modeled type 2 diabete. Gen Comp Endocrinol. 252:142–149. 2017. View Article : Google Scholar : PubMed/NCBI
22	Medina A, Nakagawa Y, Ma J, Li L, Hamano K, Akimoto T, Ninomiya Y and Kojima I: Expression of the glucose-sensing receptor T1R3 in pancreatic islet: Changes in the expression levels in various nutritional and metabolic states. Endocr J. 61:797–805. 2014. View Article : Google Scholar : PubMed/NCBI
23	Kyriazis GA, Smith KR, Tyrberg B, Hussain T and Pratley RE: Sweet taste receptors regulate basal insulin secretion and contribute to compensatory insulin hypersecretion during the development of diabetes in male mice. Endocrinology. 155:2112–2121. 2014. View Article : Google Scholar : PubMed/NCBI
24	Wang F, Song X, Zhou L, Liang G, Huang F, Jiang G and Zhang L: The downregulation of sweet taste receptor signaling in enteroendocrine L-cells mediates 3-deoxyglucosone-induced attenuation of high glucose-stimulated GLP-1 secretion. Arch Physiol Biochem. 124:430–435. 2018. View Article : Google Scholar : PubMed/NCBI
25	Kato H, van Chuyen N, Shinoda T, Sekiya F and Hayase F: Metabolism of 3-deoxyglucosone, an intermediate compound in the maillard reaction, administered orally or intravenously to rats. Biochim Biophys Acta. 1035:71–76. 1990. View Article : Google Scholar : PubMed/NCBI
26	Liang G, Wang F, Song X, Zhang L, Qian Z and Jiang G: 3-Deoxyglucosone induces insulin resistance by impairing insulin signaling in HepG2 cells. Mol Med Rep. 13:4506–4512. 2016. View Article : Google Scholar : PubMed/NCBI
27	Chlebus M, Guillen J and Prins JB: Directive 2010/63/EU: Facilitating full and correct implementation. Lab Anim. 50:1512016. View Article : Google Scholar : PubMed/NCBI
28	Yamada H, Miyata S, Igaki N, Yatabe H, Miyauchi Y, Ohara T, Sakai M, Shoda H, Oimomi M and Kasuga M: Increase in 3-deoxyglucosone levels in diabetic rat plasma. Specific in vivo determination of intermediate in advanced Maillard reaction. J Biol Chem. 269:20275–20280. 1994.PubMed/NCBI
29	Asfari M, Janjic D, Meda P, Li G, Halban PA and Wollheim CB: Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology. 130:167–178. 1992. View Article : Google Scholar : PubMed/NCBI
30	Kang MY, Oh TJ and Cho YM: Glucagon-like peptide-1 increases mitochondrial biogenesis and function in INS-1 rat insulinoma cells. Endocrinol Metab (Seoul). 30:216–220. 2015. View Article : Google Scholar : PubMed/NCBI
31	Bo J, Xie S, Guo Y, Zhang C, Guan Y, Li C, Lu J and Meng QH: Methylglyoxal impairs insulin secretion of pancreatic β-Cells through increased production of ROS and mitochondrial dysfunction mediated by upregulation of UCP2 and MAPKs. J Diabetes Res. 2016:20298542016. View Article : Google Scholar : PubMed/NCBI
32	Hamano K, Nakagawa Y, Ohtsu Y, Li L, Medina J, Tanaka Y, Masuda K, Komatsu M and Kojima I: Lactisole inhibits the glucose-sensing receptor T1R3 expressed in mouse pancreatic β-cells. J Endocrinol. 226:57–66. 2015. View Article : Google Scholar : PubMed/NCBI
33	Zhou L, Huang W, Xu Y, Gao C, Zhang T, Guo M, Liu Y, Ding J, Qin L, Xu Z, et al: Sweet taste receptors mediated ROS-NLRP3 inflammasome signaling activation: Implications for diabetic nephropathy. J Diabetes Res. 2018:70782142018. View Article : Google Scholar : PubMed/NCBI
34	Elmhiri G, Barella LF, Vieau D, Camous S, Mathias PC and Abdennebi-Najar L: Acute exposure to a precursor of advanced glycation end products induces a dual effect on the rat pancreatic islet function. Int J Endocrinol. 2014:3782842014. View Article : Google Scholar : PubMed/NCBI
35	Mace OJ, Affleck J, Patel N and Kellett GL: Sweet taste receptors in rat small intestine stimulate glucose absorption through apical GLUT2. J Physiol. 582:379–392. 2007. View Article : Google Scholar : PubMed/NCBI
36	Ashraf JM, Shahab U, Tabrez S, Lee EJ, Choi I, Aslam Yusuf M and Ahmad S: DNA glycation from 3-deoxyglucosone leads to the formation of AGEs: Potential role in cancer auto-antibodies. Cell Biochem Biophys. 74:67–77. 2016. View Article : Google Scholar : PubMed/NCBI
37	Hecker M and Wagner AH: Role of protein carbonylation in diabetes. J Inherit Metab Dis. 41:29–38. 2018. View Article : Google Scholar : PubMed/NCBI
38	Aldini G, Dalle-Donne I, Facino RM, Milzani A and Carini M: Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls. Med Res Rev. 27:817–868. 2007. View Article : Google Scholar : PubMed/NCBI
39	Thorens B: GLUT2, glucose sensing and glucose homeostasis. Diabetologia. 58:221–232. 2015. View Article : Google Scholar : PubMed/NCBI
40	Song Z, Wang H, Zhu L, Han M, Gao Y, Du Y and Wen Y: Curcumin improves high glucose-induced INS-1 cell insulin resistance via activation of insulinsignaling. Food Funct. 6:461–469. 2015. View Article : Google Scholar : PubMed/NCBI
41	Guillam MT, Hümmler E, Schaerer E, Yeh JI, Birnbaum MJ, Beermann F, Schmidt A, Dériaz N and Thorens B: Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Nat Genet. 17:327–330. 1997. View Article : Google Scholar : PubMed/NCBI